237 related articles for article (PubMed ID: 20456998)
1. Crosstalk between TNF and glucocorticoid receptor signaling pathways.
Van Bogaert T; De Bosscher K; Libert C
Cytokine Growth Factor Rev; 2010 Aug; 21(4):275-86. PubMed ID: 20456998
[TBL] [Abstract][Full Text] [Related]
2. Modelling the glucocorticoid receptor and producing therapeutic agents with anti-inflammatory effects but reduced side-effects.
McMaster A; Ray DW
Exp Physiol; 2007 Mar; 92(2):299-309. PubMed ID: 17138619
[TBL] [Abstract][Full Text] [Related]
3. Novel therapeutic agents targeting the glucocorticoid receptor for inflammation and cancer.
Sommer P; Ray DW
Curr Opin Investig Drugs; 2008 Oct; 9(10):1070-7. PubMed ID: 18821468
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of glucocorticoid receptor signaling during inflammation.
Smoak KA; Cidlowski JA
Mech Ageing Dev; 2004; 125(10-11):697-706. PubMed ID: 15541765
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms for modulating TNF alpha in immune and inflammatory disease.
Baugh JA; Bucala R
Curr Opin Drug Discov Devel; 2001 Sep; 4(5):635-50. PubMed ID: 12825458
[TBL] [Abstract][Full Text] [Related]
6. Corticosteroids: the drugs to beat.
Barnes PJ
Eur J Pharmacol; 2006 Mar; 533(1-3):2-14. PubMed ID: 16436275
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor and anti-tumor necrosis factor therapies.
Keystone EC; Ware CF
J Rheumatol Suppl; 2010 May; 85():27-39. PubMed ID: 20436163
[TBL] [Abstract][Full Text] [Related]
8. The molecular complexity of glucocorticoid actions in inflammation - a four-ring circus.
Goulding NJ
Curr Opin Pharmacol; 2004 Dec; 4(6):629-36. PubMed ID: 15525555
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoids and tumor necrosis factor-alpha synergize to induce absorption by the epithelial sodium channel in the colon.
Bergann T; Zeissig S; Fromm A; Richter JF; Fromm M; Schulzke JD
Gastroenterology; 2009 Mar; 136(3):933-42. PubMed ID: 19185581
[TBL] [Abstract][Full Text] [Related]
10. TNF-mediated inflammatory disease.
Bradley JR
J Pathol; 2008 Jan; 214(2):149-60. PubMed ID: 18161752
[TBL] [Abstract][Full Text] [Related]
11. Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?
Newton R; Holden NS
Mol Pharmacol; 2007 Oct; 72(4):799-809. PubMed ID: 17622575
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoids and the innate immune system: crosstalk with the toll-like receptor signaling network.
Chinenov Y; Rogatsky I
Mol Cell Endocrinol; 2007 Sep; 275(1-2):30-42. PubMed ID: 17576036
[TBL] [Abstract][Full Text] [Related]
13. Drug insight: selective agonists and antagonists of the glucocorticoid receptor.
McMaster A; Ray DW
Nat Clin Pract Endocrinol Metab; 2008 Feb; 4(2):91-101. PubMed ID: 18212811
[TBL] [Abstract][Full Text] [Related]
14. Molecular interaction between the glucocorticoid receptor and MAPK signaling pathway: a novel link in modulating the anti-inflammatory role of glucocorticoids.
Kharwanlang B; Sharma R
Indian J Biochem Biophys; 2011 Aug; 48(4):236-42. PubMed ID: 22053692
[TBL] [Abstract][Full Text] [Related]
15. Dominance of the strongest: inflammatory cytokines versus glucocorticoids.
Dejager L; Vandevyver S; Petta I; Libert C
Cytokine Growth Factor Rev; 2014 Feb; 25(1):21-33. PubMed ID: 24412262
[TBL] [Abstract][Full Text] [Related]
16. DBM1285 suppresses tumor necrosis factor alpha production by blocking p38 mitogen-activated protein kinase/mitogen-activated protein kinase-activated protein kinase 2 signaling pathway.
Kang JS; Kim HM; Choi IY; Han SB; Yoon YD; Lee H; Park KH; Cho IJ; Lee CW; Lee K; Lee KH; Park SK
J Pharmacol Exp Ther; 2010 Aug; 334(2):657-64. PubMed ID: 20427474
[TBL] [Abstract][Full Text] [Related]
17. Dissociated glucocorticoid receptor ligands.
Schäcke H; Rehwinkel H
Curr Opin Investig Drugs; 2004 May; 5(5):524-8. PubMed ID: 15202726
[TBL] [Abstract][Full Text] [Related]
18. Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients.
Matthews JG; Ito K; Barnes PJ; Adcock IM
J Allergy Clin Immunol; 2004 Jun; 113(6):1100-8. PubMed ID: 15208591
[TBL] [Abstract][Full Text] [Related]
19. How to modulate inflammatory cytokines in liver diseases.
Tilg H; Kaser A; Moschen AR
Liver Int; 2006 Nov; 26(9):1029-39. PubMed ID: 17032402
[TBL] [Abstract][Full Text] [Related]
20. Anti-TNF-alpha therapies: the next generation.
Palladino MA; Bahjat FR; Theodorakis EA; Moldawer LL
Nat Rev Drug Discov; 2003 Sep; 2(9):736-46. PubMed ID: 12951580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
